Makes digital forensics technology that extracts and analyzes data from mobile devices for law enforcement and investigations.
Makes digital forensics technology that extracts and analyzes data from mobile devices for law enforcement and investigations.
Sells subscriptions and licences to law enforcement, increasingly annual contracts for forensic software, with a smaller part from perpetual licences and hardware. Sales go through direct teams and resellers. It listed in the US in 2021 through a merger with a blank-check company.
Moat: narrow (regulatory licence, IP / patents, installed base). Deep law-enforcement relationships and specialized forensic technology create high barriers to entry.
Headquarters: Petah Tikva, Israel · Founded: 1999 · Employees: 1,285
Size Cellebrite DI (CLBT) is a United States Information Technology company (Packaged Software) with a market value of $2.80B, the 1586th largest of 3,085 United States companies the cockpit tracks. Shares closed at $11.16 on 18 Nov 2026.
Performance Over six months the shares fell 14.5%, against -15.5% for the median peer and -2.2% for the United States market (cap-weighted) — 11th highest of 21 in its peer set.
Growth Revenue grew 17.9% over the last twelve months (peer median +9.9%); the operating margin is 12.6% (peer median 6.4%).
Valuation It trades at 30.1× forward earnings against a peer median of 20.3× (4th most expensive of 17).
Price implies For today's price to make sense, revenue must grow about 17% a year for seven years (Req g). Recent delivered growth is +20%, so the hurdle is -2 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 34.6 points above its cost of capital (10.3% WACC).
Backlog Backlog (remaining performance obligations) was $345M at 30 Jun 2025. Backlog detail →
Short interest Short interest is 2.2% of the free float (30 Oct 2026).
Next results Next results expected around 17 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $537M | $476M | $401M | $325M | $271M |
| Revenue growth | — | +19% | +23% | +20% | — |
| Gross profit | $442M | $401M | $339M | $272M | $220M |
| EBITDA | $96.8M | $82.7M | $67.7M | $43.3M | $12.2M |
| Net income | $64.7M | $77.8M | -$283M | -$81.1M | $116M |
| Free cash flow | $166M | $160M | $124M | $96.8M | $13.7M |
| Capital expenditure | $38.9M | $13.2M | $10.6M | $7.92M | $9.09M |
| Total debt | $23.4M | $22.7M | $11.0M | $14.1M | $15.4M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Cellebrite DI CLBT | $2.80B | -14% | +18% | 13% | 30.1× | 17.1% |
| Open Text OTEX.TO | $5.55B | +5% | -1% | 23% | 6.0× | -6.8% |
| Cognyte Software CGNT | $586M | -20% | +28% | 5% | 12.5× | 22.0% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | CLBT | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -1.9% | -4.6% | 7th highest of 21 |
| 6-month return | -14.5% | -15.5% | 11th highest of 21 |
| Distance from 52-week high | -44.1% | -46.2% | 10th highest of 21 |
| Revenue growth (TTM) | +17.9% | +9.9% | 7th highest of 21 |
| Operating margin | 12.6% | 6.4% | 8th highest of 21 |
| Forward P/E | 30.1× | 20.3× | 4th most expensive of 17 |
| Growth the price implies (Req g, 7 yrs) | 17.1% | 14.4% | 6th most demanding of 16 |
| Growth delivered (Del g) | +19.5% | +14.8% | 4th highest of 16 |
| Hurdle (Req g minus delivered) | -2.4 pp | -1.6 pp | 8th least demanding of 16 |
| ROIC minus cost of capital | +34.6 pp | -2.9 pp | 2nd highest of 18 |
| EV / EBITDA | 24.2× | 15.4× | 3rd most expensive of 11 |
| Net debt / EBITDA | -4.8× | -0.2× | 2nd least indebted of 11 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Cellebrite DI CLBT | United States | $2.80B | -14% | +18% | 13% | 30.1× | 17.1% | +19.5% |
| SPS Commerce SPSC | United States | $2.81B | +47% | +7% | 17% | 14.8× | 7.1% | +19.2% |
| Vertex VERX | United States | $2.81B | +28% | +10% | 2% | 17.5× | 46.2% | +14.8% |
| Perfect World 002624.SZ | China | $2.78B | -39% | -8% | 8% | 20.4× | 15.5% | -8.2% |
| Urban URBANCO.NS | India | $2.85B | +42% | +36% | -26% | n/a | n/a | n/a |
| Tata Technologies TATATECH.NS | India | $2.85B | -2% | +22% | 13% | 34.5× | 28.2% | +18.3% |
| Shenzhen Infogem Technologies 300085.SZ | China | $2.75B | -33% | +2% | -11% | n/a | n/a | n/a |
| DHC Software 002065.SZ | China | $2.87B | -25% | -4% | 3% | 37.3× | 13.8% | +7.1% |
| Sinch SINCH.ST | Sweden | $2.88B | +7% | -3% | 4% | 13.0× | 20.6% | +27.5% |
| Beijing Shiji Information Technology 002153.SZ | China | $2.71B | -28% | -4% | -3% | 441.3× | n/a | n/a |
| Wix.com WIX | United States | $2.66B | +16% | +14% | -4% | 11.0× | -4.1% | +15.2% |
| JWIPC Technology 001339.SZ | China | $2.65B | -28% | +41% | 21% | 20.2× | n/a | n/a |
| Tsinghua Tongfang 600100.SS | China | $3.00B | -28% | -11% | -2% | n/a | 29.5% | -10.3% |
| Bullish BLSH | United States | $3.06B | -45% | +34% | 16% | 25.3× | 31.7% | +14.4% |
| Shijiazhuang Changshan Beiming Technology 000158.SZ | China | $3.08B | -26% | -14% | 2% | n/a | n/a | n/a |
| ePlus PLUS | United States | $2.52B | +17% | +12% | 7% | 16.2× | 6.2% | +9.5% |
| monday.com MNDY | United States | $3.13B | -6% | +22% | 6% | 10.2× | 14.4% | +50.2% |
| Intsig Information 688615.SS | China | $2.49B | -39% | +24% | 22% | 29.6× | 9.2% | +22.1% |
| Hexaware Technologies HEXT.NS | India | $3.18B | -5% | +13% | 12% | 21.0× | 14.9% | +16.5% |
| XD, Inc. 2400.HK | Hong Kong | $2.47B | -25% | +6% | 26% | 10.6× | 0.7% | +14.3% |
| Alarm.com ALRM | United States | $3.26B | +51% | +9% | 13% | 22.2× | 10.5% | +10.3% |
Cellebrite DI reported $345M of remaining performance obligations at 30 Jun 2025.